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Abstract
Background: Despite advances in expression technologies, the efficient production of
heterologous secreted proteins in Escherichia coli remains a challenge. One frequent limitation relies
on their inability to be exported to the E. coli periplasm. However, recent studies have suggested
that translational kinetics and signal sequences act in concert to modulate the export process.
Results: In order to produce leech carboxypeptidase inhibitor (LCI) in the bacterial periplasm, we
compared expression of the natural and optimized gene sequences, and evaluated export efficiency
of LCI fused to different signal sequences. The best combination of these factors acting on
translation and export was obtained when the signal sequence of DsbA was fused to an E. coli
codon-optimized mature LCI sequence. When tested in high cell density cultures, the protein was
primarily found in the growth medium. Under these conditions, the engineered expression system
yields over 470 mg.l-1 of purified active LCI.
Conclusion: These results support the hypothesis that heterologous secreted proteins require
proper coupling between translation and translocation for optimal high-level production in E. coli.
Background
Escherichia coli is by far the simplest, but one of the most
widely used host cell for the production of recombinant
proteins [1]. Nevertheless, the efficient translocation
across the inner membrane and proper periplasmic fold-
ing of eukaryotic proteins stabilized by multiple disulfide
bonds remains challenging for this organism [2]. Unfortu-
nately, many proteins of which there is a great biotechno-
logical or biomedical interest are secreted proteins
containing essential disulfide bonds for their native struc-
ture. Either premature cytoplasmic protein folding or
incorrect disulfide bond formation in the bacterial peri-
plasm are two known limitations in the overproduction of
secreted proteins [3]. Recently, it has been reported that
signal sequences promoting co-translational transloca-
tion improved the translocation of heterologous proteins
[4]. Therefore, targeting these recombinant precursors to
the cotranslational signal recognition particle (SRP)
dependent pathway conceivably could result in much
higher levels of periplasmic proteins than directing them
posttranslationally to the SecYEG translocase [5]. Strate-
gies to overcome folding problems due to disulfide bond
formation have primarily focused on the co-production of
protein disulfide isomerases [3]. For example, the over-
production of DsbC, a periplasmic thiol isomerase,
resulted in large amounts of native human tissue plas-
minogen activator [6].
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Microbial Cell Factories 2009, 8:57 http://www.microbialcellfactories.com/content/8/1/57In the present study, we have investigated the production
of leech carboxypeptidase inhibitor (LCI) in the peri-
plasm of E. coli. This protein is composed of 66 amino
acid residues forming a globular domain with five-
stranded β-sheet and a short α-helix that are stabilized by
four disulfide bonds [7]. Like other small disulfide-rich
proteins, the active conformation of LCI is strictly depend-
ent upon the correct formation of disulfide bonds [8].
Found in the digestive track of leeches, LCI is a strong
inhibitor of human pancreatic and plasma carboxypepti-
dases, and thus has considerable biomedical interest [9].
Indeed, by targeting the thrombin-activatable fibrinolysis
inhibitor (TAFI) involved in hemostasis, LCI could play
an important role in thrombotic disorder therapy [10].
The binding and inhibition activity of LCI is primarily
exerted by its C-terminal extremity that interacts with the
active site of metallo-carboxypeptidases. In order to over-
produce LCI in the periplasm, an E. coli codon-optimized
sequence and different signal sequences were evaluated
using a tightly controlled expression vector, suitable for
high cell density cultures.
Results and Discussion
Construction of LCI precursors
Native LCI has been previously produced in E. coli using
the signal sequence of OmpA (OmpAss), but the low yield
of secreted protein and plasmid instability precluded any
development requiring large-scale production [9]. We
decided to investigate several expression parameters in
order to improve the production of LCI in the periplasm
of E. coli. The gene encoding the mature LCI protein
(LCIN), as determined from the medical leech Hirudo
medicinalis [9], contains 7 codons that are used at a fre-
quency below 8 per 1000 in E. coli [11]. We hypothesized
that a biased codon usage might limit its expression level.
Since other non-optimal codons for E. coli are also present
in LCIN, a whole synthetic coding sequence with codon
usage optimized for E. coli was designed. The resulting
LCIO sequence contains 44 codon changes over the 66
codons (figure 1). Both LCIN and LCIO were subcloned
under the control of the tightly regulated araB promoter
from the pLCB vector encoding chloramphenicol resist-
ance. This expression vector, derived from the pBAD33
plasmid [12], was constructed for achieving high cell den-
sity cultures. In a first attempt, we retained the original
OmpAss to evaluate the effect of codon optimization.
Next, we investigated whether the limiting expression lev-
els were only governed by its mature sequence, and tested
the production of LCIN and LCIO fused either to the signal
sequence of DsbA (DsbAss) or MalE (MalEss), two well-
studied periplasmic proteins of E. coli. We chose these sig-
nal sequences because there are known to direct co- and
post-translational export of heterologous precursors
through the SRP- and Sec-dependent pathways, respec-
tively [5]. Besides translocation modes, it was recently
shown that a biased codon usage in signal sequences may
also play a role in the coupling of translation to protein
export, by slowing down the translation rate [13]. There-
fore, we decided to use the natural signal sequences of E.
coli for targeting the various LCI precursors (preLCI) to the
SecYEG translocase.
MalEss and DsbAss promote high-level of LCI in the 
periplasm
All expression vectors were transformed into the LMG194
strain in which arabinose is not catabolized because of a
deletion encompassing most of the araBAD operon [12].
The corresponding cells were cultured at 37°C in LB
media supplemented with chloramphenicol. After 2 h of
induction, LCI expression appeared to slow down cell
growth progressively (figure 2). When growth stops, a
higher density was achieved for cells expressing LCI fused
to MalEss or DsbAss than for those expressing LCI fused to
OmpAss, independent of codon optimization. This obser-
vation suggested that the physiological state of the corre-
sponding cells could be affected. We took advantage of
the carboxypeptidase inhibitory activity of LCI as a relia-
Codon optimization of the mature LCI sequenceFigure 1
Codon optimization of the mature LCI sequence. The 
natural and E. coli optimized nucleotide sequences coding the 
mature LCI, indicated in blue, are aligned. Codons occurring 
at a frequency below 8‰ in E. coli are underlined and codon 
changes are indicated in red. The codon adaptation index or 
CAI [28] shifts from 0.209 for the natural sequence to 0.622 
for the optimized sequence.Page 2 of 6
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Microbial Cell Factories 2009, 8:57 http://www.microbialcellfactories.com/content/8/1/57ble indicator of active protein to detect its presence in
both whole cell lysates and culture supernatants. Indeed,
it was previously reported that periplasmic LCI could be
released into the growth medium [9], as frequently
observed for small exported proteins [14]. Table 1 shows
the distribution of active LCI between cells and culture
supernatants determined from the six expression vectors.
Cells expressing LCI fused either to DsbAss or MalEss dis-
played higher levels of activity than those expressing LCI
with OmpAss (Table 1). If the LCI protein is unable to
fold within the reductive environment of the cytoplasm
[15], these data could reflect differences in the efficiency
of export of the different LCI precursors (see below).
However, active LCI was found in the culture supernatants
when cells expressed the E. coli optimized gene, suggesting
also a translational effect. To assess the steady-state pro-
duction and cellular location of LCI, cells were fraction-
ated from spheroplasts. Regardless of the signal sequence
used, figure 3 shows the accumulation of large amounts of
preLCI for all expression vectors. In addition, expression
from LCIopt was markedly higher than from LCIN, consist-
ent with increased translation rate. Nevertheless, for cells
expressing LCI fused to OmpAss, little or no protein was
detectable in the periplasmic fractions while preLCIs were
correctly produced. This result indicated that LCI export
did not occur to any significant extent when OmpAss was
used, and also confirmed previous findings [9]. It is note-
worthy that growth of the corresponding cells was severely
inhibited. The relative amounts of precursor (p) and
mature (m) LCI were assessed, and export efficiency (m/
p) evaluated for each expression vectors (Table 2). To
ensure that all periplasmic contents were released during
spheroplast preparation, we compared m/p ratios deter-
mined from whole cell extracts to those determined from
subcellular fractions (Table 2). Because both values are
similar, it can be concluded that: (i) a complete release of
the periplasmic mature LCI had been attained, and (ii) all
preLCIs remained in the soluble cytoplasmic fractions.
Besides OmpAss, our results indicated that the two other
preLCIs with optimized E. coli codons could give rise to a
high level of periplasmic expression (figure 3C). The high-
est export efficiency was observed with LCIO fused to
DsbAss. Interestingly, amounts of LCI in the culture
supernatants (Table 1) correlated with their levels in the
corresponding periplasmic fractions, suggesting that the
presence of extracellular LCI resulted from a direct leakage
of the outer membrane. Although the level of LCI when
fused to MalEss was somewhat lower than when fused to
DsbAss, the efficient export of preLCI may require a co-
translocation mode. Since pDsbALCIo seemed to be a
good expression vector, we checked its stability on selec-
tion pressure. After different cultivation times, bacteria
were plated onto solid LB media with and without chlo-
ramphenicol in the presence of arabinose. After overnight
growth, the number of colony forming units (CFU) deter-
mined from these plates indicated no plasmid loss (see
below).
High level production of LCI in a fermentor
The batch production of LMG194 cells transformed with
pDsbALCIo was performed at 37°C in the HDM medium,
a balanced complex medium previously optimized for
high cell density cultures in multiple microfermentors
[16]. Addition of arabinose was performed at an OD600
value of 16, equivalent to 5.5 g dry cell weight (DCW) per
liter, and the culture continued to grow during the next 8-
h period (figure 4). The level of periplasmic LCI increased
up to 5 h after induction, then decreased progressively. In
contrast, the level of extracellular LCI increased continu-
ously until a cultivation time of 8 h, resulting in most of
the overproduced protein being found in the culture
supernatants. This result suggested that a high concentra-
tion of periplasmic LCI is required before being released
into the growth medium, presumably because of an
increased permeability of the outer membrane. Although
that the mechanism of this non- or semi-specific [2] pro-
tein secretion is still unclear, it was proposed that the high
level production of secreted protein could inhibit the syn-
thesis of outer membrane proteins, and compromise the
permeability barrier of outer membrane. Therefore, we
checked the viability of cells during cultivation in the fer-
mentor, and in parallel experiments we monitored CFU
counts for plasmid loss. The data shown in figure 5 indi-
cate that about 90% of cells were still alive and able to
form colonies on selective plates. The accumulated LCI in
the growth medium during high cell density culture did
not result from cell lysis or death. Finally, after 8 h of
induction, about 470 mg of active LCI could be purified
from 1 liter of culture by a single step reverse-phase chro-
matography.
Table 1: Distribution of native LCI between cells and culture medium
pOmpALCIN pOmpALCIO pDsbALCIN pDsbALCIO pMalEssLCIN pMalEssLCIO
Whole cell lysates 53 33.5 147.5 154.5 104 125.5
Culture supernatants nd nd nd 12.5 nd 4
The level of LCI (mg. l-1) in these fractions was assayed by a spectrophotometric assay using bovine carboxypeptidase A, and normalized to protein 
content of whole cell lysates determined by the Bradford procedure using bovine serum albumin as a standard (nd, not detectable).Page 3 of 6
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In this study, we found that E. coli codon optimization in
the LCI gene when combined to the signal sequence of
DsbA allowed the production/purification of 470 mg of
active LCI per liter of culture. While codon usage may be
an important criterion for translation rate [17,18] and/or
protein folding [18-20], our studies indicate that, besides
the nature of signal sequence, it is also an important
parameter to ensure an efficient export of heterelogous
precursors. If the nature of signal sequence determines the
targeting pathways [21], the correct combination of both
parameters appears to be necessary for optimal coupling
of translation to protein translocation in E. coli.
Methods
Bacterial strain and plasmids
The E. coli LMG194 strain [F- ΔlacX74 galE galK thi rpsL
ΔphoA Δara714 leu::Tn10] carrying the araBAD deletion
[12] was used as the expression host throughout the
experiments. Recombinant DNA manipulations were per-
formed as described in established protocols [22]. Plas-
mid pLCB was constructed in two steps from the pBAD33
expression vector [12]. First, the residual bla sequence was
deleted by BglI-Tth111I digestion and filling in with Kle-
now fragment. Second, a DNA fragment which contained
the Shine-Dalgarno sequence comprising an ATG start
codon within a NdeI site from the pIVEX2.3MCS vector
[23] was amplified using 5'-AAGAGCTCGAATTCCATAT-
GTATATCTCCTTGCTAG CCCAAAAAAACGGGTATGG-3'
Table 2: Export efficiency of preLCI
pOmpALCIN pOmpALCIO pDsbALCIN pDsbALCIO pMalEssLCIN pMalEssLCIO
R1 0.4 0.1 1.3 4.8 1.0 1.8
R2 0.2 0.01 1.1 5.7 0.9 1.5
The relative amount of precursor (p) and mature (m) LCI present in each gel shown in figure 3 was assessed by densitometric scanning and the 
ratio R (m/p) was determined from whole cell lysates (R1), and from cytoplasmic and periplasmic fractions (R2).
Growth curves of E. coli expressing LCI in shake-flask cul-tu esFigure 2
Growth curves of E. coli expressing LCI in shake-flask 
cultures. LMG194 cells carrying pLCB (open circle), pOm-
pAssLCIN (black circle), pOmpAssLCIO (black square), pDs-
bAssLCIN(red circle), pDsbALCIO (red square), pMalEssLCIN 
(blue circle), and pMalEssLCIO (blue square), were grown at 
37°C in LB medium supplemented with 30 μg.ml-1 chloram-
phenicol. Induction by arabinose (0.2% final) was performed 












Steady-state level and cellular location of LCIFigure 3
Steady-state level and cellular location of LCI. Whole 
cell lysates (A), cytoplasmic fractions (B), and periplasmic 
fractions (C) were separated by SDS-PAGE and stained by 
Coomassie blue. Lanes 1, pLCB; lanes 2, pOmpAssLCIN; 
lanes 3, pOmpAssLCIO; lanes 4, pMalEssLCIN; lanes 5, pMa-
lEssLCIO; lanes 6, pDsbAssLCIN; lanes 7, pDsbALCIO. The 
position of precursor (p) and mature (m) LCI is indicated by 
an arrow.
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and pBAD33 as DNA template. The PCR product was
digested with MluI and SacI, and cloned into the same
restriction sites of the previous pBAD33 derivative. The
structure of the resulting plasmid was confirmed by
sequencing and designated as pLCB. The mature LCI
sequence was codon optimized for E. coli expression and
chemically synthesized by Geneart (Regensburg, Ger-
many). The substitution of malE or dsbA signal sequence
was generated by overlap extension PCR as previously
described [24].
Growth conditions
For shake flask cultures, cells were grown in 100 ml of LB
medium supplemented with chloramphenicol (30 μg.ml-
1). Induction of the araB promoter was accomplished by
addition of L-arabinose to a final concentration of 0.2%.
After 6 h at 37°C, cells were harvested by centrifugation at
6,000 rpm for 15 min. For high cell density cultures, bac-
teria were grown in a Sartorius Biostat B® 2-L fermentor at
37°C. The aeration rate and stirrer speed were regulated to
keep the dissolved oxygen concentration at 60% of its sat-
uration value. Precultures (80 ml) were prepared in shake
flasks at 37°C to mid-log phase, and then added into the
fermentor containing 800 ml of the HDM medium [16]
supplemented with chloramphenicol (30 μg.ml-1). Induc-
tion was accomplished by addition of L-arabinose (0.5%).
Cell biomass was monitored by measuring both the opti-
cal density at 600 nm (OD600) and dry cell weight (DCW)
as previously described [25]. Cell viability was determined
by using the LIVE/DEAD BacLight kit (Invitrogen) in com-
bination with flow cytometry as described by the manu-
facturer [26]. Plasmid stability was assessed by plating
properly diluted amounts of culture samples on LB-agar
plates containing 0.5% arabinose without antibiotic and
with 30 μg.ml-1 chloramphenicol. After overnight growth
at 37°C the numbers of colony forming unit (CFU) were
determined.
Cell fractionation and protein assays
Cells carrying the pLCB derivatives, normalized to the
same OD600, were fractionated by spheroplast preparation
as previously described [27]. To analyse secreted LCI in
the culture media, culture supernatants were applied to
SepPak Plus C18 cartridges (Waters) pre-equilibrated by
10% acetonitrile. Then, the columns were washed with
10% acetonitrile, and proteins were eluted by 30% isopro-
panol. Total protein content was determined by the Brad-
ford assay using bovine serum albumin as a standard.
Cellular fractions were separated on 10% Bis-Tris polyacr-
ylamide NuPage gels (Invitrogen), and proteins were vis-
ualized by Coomassie blue staining. For quantitative
analysis, gels were scanned with Gel Doc XR imaging sys-
tem (Biorad).
LCI purification
After cultivation, cells were centrifuged as described above
and supernatants were filtered through a 0.22 μm syringe
filter (Millipore). LCI was purified by reverse phase chro-
matography using a Ultimate 300 HPLC system (Dionex)
and a Vydak C4 column, with a linear gradient ranging
from 20 to 80% acetonitrile at a flow rate of 1 ml.min-1 as
previously described [9]. To quantify the concentration of
native LCI found in periplasmic and culture supernatants,
High scale production of LCIFi ure 4
High scale production of LCI. The culture of LMG194/
pDsbALCIO cells in a 2-l fermentor is shown with time 
course variations of biomass (gDCW.l-1, black circle) and dis-
tribution of active LCI (mg.l-1) between cells (red circle) and 
























Cell viability and plasmid stability in high cell density cultureFigure 5
Cell viability and plasmid stability in high cell density 
culture. Duplicate samples were taken from the high cell 
density culture shown in figure 4. From these culture sam-
ples, cell viability (%, black circle) and plasmid stability (%, red 
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a calibration curve was constructed by using purified
active protein as a standard. The LCI activity was assayed
using the Carboxypeptidase A assay kit (Sigma Aldrich) in
50 mM Tris-HCl buffer, pH 7.5; containing 100 mM NaCl.
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